Numerous pharmaceutical interventions, including angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers (CCBs), beta-blockers, and angiotensin receptor blockers (ARBs), have been suggested for the management of HF; however, none of them has demonstrated significant efficacy [8-10]. The gene discussed is ACE; the disease is hydrops fetalis.